Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis

被引：114

作者：

Boy, Mary G. ^{[1
]}

Wang, Cunshan ^{[2
]}

Wilkinson, Bethanie E. ^{[2
]}

Chow, Vincent Fung-Sing ^{[2
]}

Clucas, Alan T. ^{[2
]}

Krueger, James G. ^{[3
]}

Gaweco, Anderson S. ^{[2
]}

Zwillich, Samuel H. ^{[2
]}

Changelian, Paul S. ^{[2
]}

Chan, Gary ^{[2
]}

机构：

[1] Pfizer Inc, Div Med, New London, CT USA

[2] Pfizer Inc, Pfizer Global Res & Dev, New London, CT USA

[3] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷 / 09期

关键词：

PATHOGENESIS; INHIBITION; JAK3;

D O I：

10.1038/jid.2009.25

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：2299 / 2302

页数：5

共 6 条

[1] JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants [J].

Borie, DC ;

O'Shea, JJ ;

Changelian, PS .

TRENDS IN MOLECULAR MEDICINE, 2004, 10 (11) :532-541

[2] Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].

Changelian, PS ;

Flanagan, ME ;

Ball, DJ ;

Kent, CR ;

Magnuson, KS ;

Martin, WH ;

Rizzuti, BJ ;

Sawyer, PS ;

Perry, BD ;

Brissette, WH ;

McCurdy, SP ;

Kudlacz, EM ;

Conklyn, MJ ;

Elliott, EA ;

Koslov, ER ;

Fisher, MB ;

Strelevitz, TJ ;

Yoon, K ;

Whipple, DA ;

Sun, JM ;

Munchhof, MJ ;

Doty, JL ;

Casavant, JM ;

Blumenkopf, TA ;

Hines, M ;

Brown, MF ;

Lillie, BM ;

Subramanyam, C ;

Shang-Poa, C ;

Milici, AJ ;

Beckius, GE ;

Moyer, JD ;

Su, CY ;

Woodworth, TG ;

Gaweco, AS ;

Beals, CR ;

Littman, BH ;

Fisher, DA ;

Smith, JF ;

Zagouras, P ;

Magna, HA ;

Saltarelli, MJ ;

Johnson, KS ;

Nelms, LF ;

Des Etages, SG ;

Hayes, LS ;

Kawabata, TT ;

Finco-Kent, D ;

Baker, DL ;

Larson, M .

SCIENCE, 2003, 302 (5646) :875-878

[3] Immunopathogenic mechanisms in psoriasis [J].

Gudjonsson, JE ;

Johnston, A ;

Sigmundsdottir, H ;

Valdimarsson, H .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (01) :1-8

[4] Psoriasis pathophysiology: current concepts of pathogenesis [J].

Krueger, JG ;

Bowcock, A .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :30-36

[5] Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs [J].

Pesu, M ;

Candotti, F ;

Husa, M ;

Hofmann, SR ;

Notarangelo, LD ;

O'Shea, JJ .

IMMUNOLOGICAL REVIEWS, 2005, 203 :127-142

[6] Inhibition of keratinocyte apoptosis by IL-15:: A new parameter in the pathogenesis of psoriasis? [J].

Rückert, R ;

Asadullah, K ;

Seifert, M ;

Budagian, VM ;

Arnold, R ;

Trombotto, C ;

Paus, R ;

Bulfone-Paus, S .

JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2240-2250

← 1 →